Your browser doesn't support javascript.
loading
All-photonic kinase inhibitors: light-controlled release-and-report inhibition.
Fleming, Cassandra L; Benitez-Martin, Carlos; Bernson, Elin; Xu, Yongjin; Kristenson, Linnea; Inghardt, Tord; Lundbäck, Thomas; Thorén, Fredrik B; Grøtli, Morten; Andréasson, Joakim.
Afiliação
  • Fleming CL; Department of Chemistry and Chemical Engineering, Physical Chemistry, Chalmers University of Technology SE-41296 Göteborg Sweden a-son@chalmers.se.
  • Benitez-Martin C; Department of Chemistry and Molecular Biology, University of Gothenburg Box 462 SE-40530 Göteborg Sweden grotli@chem.gu.se.
  • Bernson E; Department of Chemistry and Chemical Engineering, Physical Chemistry, Chalmers University of Technology SE-41296 Göteborg Sweden a-son@chalmers.se.
  • Xu Y; TIMM Laboratory at Sahlgrenska Centre for Cancer Research, Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg SE-41296 Göteborg Sweden.
  • Kristenson L; Department of Chemistry and Molecular Biology, University of Gothenburg Box 462 SE-40530 Göteborg Sweden grotli@chem.gu.se.
  • Inghardt T; TIMM Laboratory, Sahlgrenska Centre for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg SE-41296 Göteborg Sweden.
  • Lundbäck T; Cardiovascular, Renal and Metabolism, Innovative Medicines and Early Development, AstraZeneca SE-43183 Mölndal Sweden.
  • Thorén FB; Mechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca SE-43183 Mölndal Sweden.
  • Grøtli M; TIMM Laboratory, Sahlgrenska Centre for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg SE-41296 Göteborg Sweden.
  • Andréasson J; Department of Chemistry and Molecular Biology, University of Gothenburg Box 462 SE-40530 Göteborg Sweden grotli@chem.gu.se.
Chem Sci ; 15(18): 6897-6905, 2024 May 08.
Article em En | MEDLINE | ID: mdl-38725520
ABSTRACT
Light-responsive molecular tools targeting kinases affords one the opportunity to study the underlying cellular function of selected kinases. In efforts to externally control lymphocyte-specific protein tyrosine kinase (LCK) activity, the development of release-and-report LCK inhibitors is described, in which (i) the release of the active kinase inhibitor can be controlled externally with light; and (ii) fluorescence is employed to report both the release and binding of the active kinase inhibitor. This introduces an unprecedented all-photonic method for users to both control and monitor real-time inhibitory activity. A functional cellular assay demonstrated light-mediated LCK inhibition in natural killer cells. The use of coumarin-derived caging groups resulted in rapid cellular uptake and non-specific intracellular localisation, while a BODIPY-derived caging group predominately localised in the cellular membrane. This concept of release-and-report inhibitors has the potential to be extended to other biorelevant targets where both spatiotemporal control in a cellular setting and a reporting mechanism would be beneficial.

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article